Brain MRI | XPRT
Articles & Whitepapers
-
A disability isn’t always visible!
In recognition of the International Day of Persons with Disabilities, we hear from one of our #SEGreatPeople on their experience of life with a ...
-
The effects of antidepressants appear to be rapid and at environmentally relevant concentrations
The effects of antidepressants on wildlife are currently raising some concern due to an increased number of publications indicating biological effects at environmentally relevant concentrations ...
News
-
Longeveron Announces Initiation of Phase 2a Clinical Trial of Lomecel-B for the Treatment of Alzheimer’s Disease
Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today the initiation of its Phase 2a ...
Arterys Partners With Cercare Medical to Offer Advanced Perfusion Brain CT and MR Imaging Analysis Accelerating Access to Deep, Fast, and Reliable Insights
Arterys Partners With Combinostics to Accelerate Accurate and Consistent Evaluations of Patients With Neurodegenerative Disease and Multiple Sclerosis
Internationally Renowned Neurosurgeon and Accomplished Researcher Dr. Linda M. Liau Joins ClearPoint Neuro Board of Directors
CorticoMetrics Announces FDA 510(k) Clearance of THINQ for MRI Brain Volumetric Reporting
Equipment & Solutions
-
Showcase
Strategically Acquired Gradient Echo
With an average of 40% faster MRI acquisition and processing, STAGE creates immediate clinical value by increasing throughput and workflow efficiency for your organization*. Given the growing constraints of reimbursement, labor costs, and space, STAGE creates an opportunity to see more patients every day while also enhancing the quality of care.
